{
    "ticker": "ACT",
    "name": "Aclaris Therapeutics, Inc.",
    "description": "Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for dermatological diseases and other conditions. Founded in 2012 and headquartered in Wayne, Pennsylvania, Aclaris aims to address unmet medical needs through the discovery and development of novel therapeutics. The company is known for its proprietary technology platform, which enables the rapid development of drug candidates targeting various skin disorders, including alopecia areata and actinic keratosis. Aclaris is committed to advancing its pipeline of product candidates, utilizing a combination of chemical entities and biologics. In addition to its development efforts, Aclaris engages with the dermatology community to ensure its therapies align with the needs of patients and healthcare providers. With a focus on innovation and patient-centric solutions, Aclaris Therapeutics is dedicated to transforming the treatment landscape for dermatological conditions.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Wayne, Pennsylvania, USA",
    "founded": "2012",
    "website": "https://www.aclaristx.com",
    "ceo": "Dr. Neal Walker",
    "social_media": {
        "twitter": "https://twitter.com/aclaristx",
        "linkedin": "https://www.linkedin.com/company/aclaris-therapeutics/"
    },
    "investor_relations": "https://investors.aclaristx.com",
    "key_executives": [
        {
            "name": "Dr. Neal Walker",
            "position": "CEO"
        },
        {
            "name": "Michael McGowan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Dermatological Treatments",
            "products": [
                "ATI-50001",
                "ATI-50002"
            ]
        }
    ],
    "seo": {
        "meta_title": "Aclaris Therapeutics, Inc. | Innovative Dermatology Solutions",
        "meta_description": "Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative dermatological treatments. Explore Aclaris' advanced pipeline and commitment to patient care.",
        "keywords": [
            "Aclaris",
            "Biopharmaceuticals",
            "Dermatology",
            "Alopecia Areata",
            "Actinic Keratosis"
        ]
    },
    "faq": [
        {
            "question": "What does Aclaris Therapeutics focus on?",
            "answer": "Aclaris Therapeutics focuses on developing innovative treatments for dermatological diseases."
        },
        {
            "question": "Who is the CEO of Aclaris?",
            "answer": "Dr. Neal Walker is the CEO of Aclaris Therapeutics, Inc."
        },
        {
            "question": "Where is Aclaris headquartered?",
            "answer": "Aclaris is headquartered in Wayne, Pennsylvania, USA."
        },
        {
            "question": "What are Aclaris' main product candidates?",
            "answer": "Aclaris' main product candidates include ATI-50001 and ATI-50002."
        },
        {
            "question": "When was Aclaris founded?",
            "answer": "Aclaris was founded in 2012."
        }
    ],
    "competitors": [
        "VRNA",
        "CVM",
        "STOK",
        "CBAY"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BMY",
        "MRNA"
    ]
}